Scientists discover 3 new gene faults which could increase melanoma risk by 30 percent
An international team of researchers has discovered the first DNA faults linked to melanoma - the deadliest skin cancer - that are not related to hair, skin or eye colour. Cancer Research UK scientists at the University of Leeds, together with a team from the GenoMEL consortium*, scanned the genes in blood samples from almost 3000 Europeans with melanoma, and compared these with samples taken from the general population. Their findings are published in Nature Genetics.**
Read more ...
Pale people may need vitamin D supplements
Researchers at the University of Leeds, funded by Cancer Research UK, suggest that people with very pale skin may be unable to spend enough time in the sun to make the amount of vitamin D the body needs - while also avoiding sunburn. The study, published in Cancer Causes and Control*, suggested that melanoma patients may need vitamin D supplements as well. But researchers also noted that sunlight and supplements are not the only factors that can determine the level of vitamin D in a person's body. Some inherited differences in the way people's bodies process vitamin D into the active form also have a strong effect on people's vitamin D levels.
Read more ...
MVA-B Spanish HIV vaccine shows 90 percent immune response in humans
Phase I clinical trials developed by Spanish Superior Scientific Research Council (CSIC) together with Gregorio Marañón Hospital in Madrid and Clínic Hospital in Barcelona, reveals MVA-B preventive vaccine's immune efficiency against Human's immunodeficiency virus (HIV). 90% of the volunteers who went through the tests developed an immunological response against the virus and 85% has kept this response for at least one year. Safety and efficiency of this treatment have been described in articles for Vaccine and Journal of Virology science magazines.
Read more ...
High Potential for the Immune and Antihypertensive Health Ingredients Market in Europe
The rising incidence of problems related to high blood pressure and weak immune system as well as the gravitation toward preventive healthcare is driving the European market for nutritional solutions in immune and antihypertensive health. The swine flu epidemic that hit Europe and the United States is one of the factors that boosted consumer interest in maintaining a healthy immune system.
Read more ...
ecancerHub - A New Approach to Cancer Communication
eurocancercoms has announced the launch of ecancerHub - a new, open-access, integrated approach to providing the whole cancer community - patients, doctors, researchers and policymakers - with high quality and trustworthy information. Integrating the best of social media technology into one unique platform, ecancerHub enables patients, healthcare professionals and researchers to interact, connect and share. They have the opportunity to discuss, debate, generate new ideas, gather opinions and build knowledge not only within their own groups, but also cross-community.
Read more ...
Based on the recommendations of the IMI Research Agenda, the IMI Governing Board has approved the IMI Annual Implementation Plan 2011, including the Scientific Priorities 2011. These priorities have been incorporated into the IMI 4th Call Topics. These priorities have been incorporated into the IMI 4th Call Topics. Applicants intending to submit an Expression of Interest (EoI) in response to the IMI 4th Call should read the Guide for Applicants, the Call Topics, the Rules for Participation, the Rules for Submission, Evaluation and Selection of EoIs and FPPs, the IMI IPR rules and the IMI JU model Grant Agreement.
Read more ...
VTU Technology Launches Breakthrough Technology for High Level Methanol-free Protein Expression
VTU Technology, a leading contract research and development company providing services for the fast-track generation of high-performance industrial protein expression strains and processes for the biopharmaceutical and other protein industries announces the launch of their 2nd generation AOX1 promoter variants allowing for methanol-free protein expression in Pichia pastoris.
Read more ...